# Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

> **NCT00892749** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 248 (actual)

## Conditions studied

- Chronic Kidney Disease
- Renal Dialysis
- Renal Insufficiency
- Hyperphosphatemia

## Interventions

- **DRUG:** ASP1585

## Key facts

- **NCT ID:** NCT00892749
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2015-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00892749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00892749, "Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00892749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*